Bendamustine, Wkly Bortezomib, Lenalidomide and Dexamethasone for Multiple Myeloma

NCT01484626 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Celgene would no longer supply lenalidomide for the study

Conditions

Multiple Myeloma

Interventions

DRUG: Bendamustine

Sponsor

Loyola University

Collaborators

[object Object]